Evaluation of two anti-hepatitis e virus lgM kits

Biomedical and Environmental Sciences

Volumn 20, Issue 6, 2007, Pages 512-515

  Ge, Sheng Xiang ^a   Zheng, Ying Jie ^b   Guo, Qing Shun ^a   Zhang, Jun ^a   Jiang, Qing Wu ^b   Ng, Mun Hon ^a   Xia, Ning Shao ^a  

^a XIAMEN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

IgM anti HEV; Viral hepatitis

Indexed keywords

IMMUNOGLOBULIN M;

ANALYTICAL EQUIPMENT; ARTICLE; BLOOD; DIFFERENTIAL DIAGNOSIS; EVALUATION; HEPATITIS E; HUMAN; IMMUNOLOGY; SENSITIVITY AND SPECIFICITY;

DIAGNOSIS, DIFFERENTIAL; HEPATITIS E; HUMANS; IMMUNOGLOBULIN M; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY;

HEPATITIS E VIRUS; PRIMATES;

EID: 38949209079     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. He J, Innis B L, Shrestha M P, et al. (2002). Evidence that rodents are a reservoir of hepatitis E virus for humans in Nepal. J Clin Microbiol 40(12), 4493-4498.
2. Arankalle V A, Joshi M V, Kulkami A M, et al. (2001). Prevalence of anti-hepatitis E virus antibodies in different Indian animal species. J Viral Hepat 8(3), 223-227.
3. Favorov M O, Kosoy M Y, Tsarev S A, et al. (2000). Prevalence of antibody to hepatitis E virus among rodents in the United States. J Infect Dis 181(2), 449-455.
4. Meng X J, Halbur P G Haynes J S, et al. (1998). Experimental infection of pigs with the newly identified swine hepatitis E virus (swine HEV), but not with human strains of HEV. Arch Virol 143(7), 1405-1415.
5. Tei S, Kitajima N, Takahashi K, et al. (2003). Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet 362(9381), 371-373.
6. Radhakrishnan S, Raghuraman S, Abraham P, et al. (2000). Prevalence of enterically transmitted hepatitis viruses in patients attending a tertiary-care hospital in south India. Indian J Pathol Microbiol 43(4), 433-436.
7. Su C W, Wu J C, Huang Y S, et al (2002). Comparison of clinical manifestations and epidemiology between acute hepatitis A and acute hepatitis E in Taiwan. J Gastroenterol Hepatol 17(11), 1187-1191.
8. Tsai J F, Jeng J E, Chang W Y, et al (1994). Antibodies to hepatitis E virus among Chinese patients with acute hepatitis in Taiwan. J Med Virol 43(4), 341-344.
9. Tan D, Im S W, Yao J L, et al (1995). Acute sporadic hepatitis E virus infection in southern China. J Hepatol 23(3), 239-245.
10. Kumar A, Beniwal M, Kar P, et al. (2004). Hepatitis E in pregnancy, bit J Gynaecol Obstet 85(3), 240-244.
11. Zhang J, Ge S X, Huang G Y, et al (2003). Evaluation of antibody-based and nucleic acid-based assays for diagnosis of hepatitis E virus infection in a rhesus monkey model. J Med Virol 71(4), 518-526.
12. Bryan J P, Tsarev S A, Iqbal M, et al (1994). Epidemic hepatitis E in Pakistan: patterns of serologic response and evidence that antibody to hepatitis E virus protects against disease. J Infect Dis 170(3), 517-521.
13. B.Bryan J P, Iqbal M, Tsarev S, et al (2002). Epidemic of hepatitis E in a military unit in Abbotrabad, Pakistan. Am J Trop Med Hyg 67(6), 662-668.
14. Tan C R, Chen M, Ge S X, et al. (2003). Serological characteristics of a hepatitis E outbreak. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 17(4), 361-364. (In Chinese)
15. Zhang J Z, Ng M H, Xia N S, et al. (2001). Conformational antigenic determinants generated by interactions between a bacterially expressed recombinant peptide of the hepatitis E virus structural protein. J Med Virol 64(2), 125-132.
16. Li S W, Zhang J, He Z Q, et al (2005). Mutational analysis of essential interactions involved in the assembly of hepatitis E virus capsid. J Biol Chem 280(5), 3400-3406.
17. Zhang J, Ge S X, Huang G Y, et al. (2004). Significance of serological markers and virological marker for hepatitis E in rhesus monkey model. Zhonghua Gan Zang Bing Za Zhi 12(1), 7-10. (In Chinese)
18. Zhang J, Gu Y, Ge S X, et al (2005). Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid protein. Vaccine 23(22), 2881-2892.
19. Im S W, Zhang J Z, Zhuang H, et al. (2001). A bacterially expressed peptide prevents experimental infection of primates by the hepatitis E virus. Vaccine 19(27), 3726-3732.
20. Li S W, Zhang J, Li Y M, et al (2005). A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine 23(22), 2893-2901.
21. Lin C C, Wu J C, Chang T T, et al (2000). Diagnostic value of immunoglobulin G (IgG) and IgM anti-hepatitis E virus (HEV) tests based on HEV RNA in an area where hepatitis E is not endemic. J Clin Microbiol 38(11), 3915-3918.